Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Few drugs have captured public attention like Ozempic; many of us have even taken it. The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug ... or liraglutide — are prescribed to treat type 2 diabetes and obesity, but previous studies have linked ...

You may take Ozempic or another drug to control your diabetes ... The research, which compared about 2 million veterans with diabetes, some of whom took the drugs and some didn't, found the ...

Click Here To Sign Up For Our Health Newsletter Novo Nordisk, the maker of Ozempic (approved for type 2 diabetes treatment and reduced risk of cardiovascular events) and Wegovy (approved for ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...